Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-13
2007-02-13
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S084000
Reexamination Certificate
active
10499251
ABSTRACT:
The present invention relates to adenosine A3receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containings them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and (III) and to the preparation thereof.
REFERENCES:
patent: 4075343 (1978-02-01), Kadin
patent: 4279912 (1981-07-01), Ager et al.
patent: 4333934 (1982-06-01), Barnes et al.
patent: 4387098 (1983-06-01), Barnes et al.
patent: 2005/0234056 (2005-10-01), Aranyi et al.
patent: 0062580 (1982-10-01), None
Tilley et al., “Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cells”, The journal of clinical investigation, 2000, vol. 105, pp. 361-367.
Shneyvays et al., “Insights into adenosine A1 and A3 receptors function: cardiotoxicity and cardioprotection”, Drug development research, vol. 50, pp. 324-337.
Ager, Ian R. et al., J. Med. Chem., vol. 31(6), pp. 1098-1115 (1988).
Clements-Jewery, Stephen et al., J. Med. Chem., vol. 31(6), pp. 1220-1226 (1988).
Arányi Péter
Balázs László
Balogh Mária
Bátori Sándor
Boer Kinga
Alexander Michael D.
Lin Jiang
Rahmani Niloofar
Sanofi-Aventis
Seaman Margaret D.
LandOfFree
Imidazoquinoline derivatives and their use as adenosine A3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoquinoline derivatives and their use as adenosine A3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoquinoline derivatives and their use as adenosine A3... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3879612